Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines

Patrizia Vici (1) , Alessandra Fabi (1) , Giulio Metro (1) , Domenico Sergi (1) , Diana Giannarelli (2) , Luigi Di Lauro (1) , Gerold Bepler (3) , Federica Tomao (4) , Francesco Cognetti (1) , Francesca Conti (1) , Massimo Lopez (1)

1 Department of Medical Oncology
2 Statistical Unit
3 Department of Thoracic Oncology
4 Department of Gynecology

Mots clés: Advanced breast cancer; Fixed-dose rate; Gemcitabine; Paclitaxel; HER2-negative breast cancer

Patrizia Vici, Alessandra Fabi, Giulio Metro, Domenico Sergi, Diana Giannarelli, et al.. Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines. Cancer Chemotherapy and Pharmacology, 2010, 67 (3), pp.687-693. ⟨10.1007/s00280-010-1369-y⟩. ⟨hal-00596691⟩